treatment options for patients with hodgkin lymphoma who have relapsed after three lines of therapy
Published 2 weeks ago • 87 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:12
optimizing treatment in hodgkin lymphoma
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
2:00
updates on treatment methods for hodgkin lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:30
the use of targeted drug therapy for aggressive lymphoma
-
1:43
the addition of immunotherapy to the front-line treatment of as hodgkin lymphoma
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
2:10
challenges in treating patients with hl who relapse after autosct & novel therapies being explored
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
3:27
therapeutic options for patients with primary refractory/early relapsed dlbcl
-
4:40
engraftment syndrome following asct in patients with checkpoint inhibitor treated hodgkin lymphoma
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
2:43
treatment sequencing options for recurrent cll
-
2:24
the treatment and management of ptld
-
1:51
checkpoint inhibition in the treatment of mpns